Effect of tDCS on Chronic Abdominal Visceral Pain in HCC Patients

Status Completed

Clinical Trial Summary

To evaluate the effect of transcranial direct current stimulation (tDCS) applied to the motor cortex to reduce chronic abdominal visceral pain in a group of participants with hepatocellular carcinoma

Clinical Trial Description

This study will be carried out in Assiut University Hospital pain clinic and in participation of department of neuropsychiatry in Assiut University Hospital. After obtaining approval of hospital ethical committee, informed written consent will be taken from all patients with malignant visceral pain to be involved in this study.

In these study investigators test the hypothesis that Does transcranial direct current stimulation induce analgesia in chronic abdominal visceral pain due to liver cancer ?

Preparation:

The patient will seat in a comfortable chair and will be asked to relax as much as possible. tDCS was delivered using a battery driven DC stimulator (neuroConn Gmbh,98693 llmenau, Germany). Current was delivered by electrodes encased in sponge pads soaked with 1% saline solution. The machine was kept behind the participant and out of their view at all times. For both the active and sham conditions, the anode was placed over the motor cortex of the patient and the cathode was placed over the contralateral supraorbital region. Electrodes were secured using soft elastic straps.

In the active stimulation condition a constant current of 2mA intensity was applied for 30 minutes with a 5-second ramp phase at the beginning. In the sham stimulation condition the machine was activated for 30 seconds using identical parameters but was then switched off without the patient's knowledge. This sham control is commonly employed because over the initial 30 seconds of stimulation, an initial sensation of tingling under the electrode fades away. Patients are less likely to distinguish active from sham conditions if the initial period of tingling is present in both.

Patients were evaluated by verbal descriptor scale (VDS), visual analog scale (VAS), and Hamilton rating scale for depression (HAM-D) at the baseline, after 1st, 5th, 10th session, and 1 month after end of sessions. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Abdominal Pain

Clinical Trial Details

NCT number	NCT02928237
Study type	Interventional
Source	Assiut University
Contact
Status	Completed
Phase	N/A
Start date	April 2015
Completion date	August 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04682860` - Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide	Phase 4
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Completed	`NCT02547857` - Transvaginal Pelvic Ultrasound in the ED	N/A
Completed	`NCT03318614` - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster	Phase 2/Phase 3
Completed	`NCT02923245` - POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound	N/A
Completed	`NCT02197780` - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD	N/A
Completed	`NCT02676232` - DARWeb: an Online Psychosocial Intervention for Children With Recurrent Abdominal Pain and Their Families.	N/A
Recruiting	`NCT00209807` - Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder	Phase 4
Terminated	`NCT01410071` - Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction	N/A
Terminated	`NCT01736280` - Evaluating and Treating Potential Research Participants With Digestive Disorders	N/A
Enrolling by invitation	`NCT04104867` - Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy	N/A
Completed	`NCT03574727` - Abdominal Cutaneous Nerve Entrapment Syndrome
Completed	`NCT04614649` - Right Iliac Fossa Treatment-Turkey Audit
Completed	`NCT05438654` - Improvement of Diagnostic Approach Using PoCUS for Right Upper Quadrant Abdominal Pain	N/A
Completed	`NCT06423586` - Effect of Lecithin-based Curcuma and Boswellia on Post-acute COVID-19 IBS	N/A
Completed	`NCT03558009` - Epidemiological Analysis for Hereditary Angioedema Disease
Terminated	`NCT03148288` - Vitamin D Supplementation in IBS	N/A
Completed	`NCT03708874` - Pain Management of Emergency Laparoscopic Cholecystectomy in Patients With Acute Cholecystitis
Withdrawn	`NCT04408872` - EUS vs EGD in Emergency Room Patients Referred for EGD	N/A
Recruiting	`NCT02594774` - Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.